HIHiroaki Itoh

Hiroaki Itoh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hiroaki Itoh has a total of 107 co-authors. Here are the top co-authors by number of shared publications:

  • Naohiro Kanayama

    Affiliation Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan

    19 shared publications
  • Toshiyuki Uchida

    Affiliation Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan

    10 shared publications
  • Chizuko Yaguchi

    Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan

    9 shared publications
  • Kazunao Suzuki

    Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan

    8 shared publications
  • Kazuhiro Sugihara

    A Department of Obstetrics & Gynecology , Hamamatsu University School of Medicine , Shizuoka , Japan

    7 shared publications
  • Naoaki Tamura

    Affiliation Department of Obstetrics and Gynecology, Hamamatsu University School of Medicine, Hamamatsu, Japan

    7 shared publications

Latest Publications

  • Open Access

    Intrauterine Hyponutrition Reduces Fetal Testosterone Production and Postnatal Sperm Count in the Mouse

    by Yasuko Fujisawa, Hiroyuki Ono, Alu Konno, Ikuko Yao, Hiroaki Itoh, Takashi Baba, Kenichirou Morohashi, Yuko Katoh-Fukui, Mami Miyado, Maki Fukami, et al.

    Background: Although intrauterine hyponutrition is regarded as a risk factor for the development of “testicular dysgenesis syndrome” (TDS) in the human, underlying mechanism(s) remain largely unknown.Methods: To clarify the underlying mechanism(s), we fed vaginal plug-positive C57BL/6N female mice with regular food ad libitum throughout the pregnant course (control females) (C-females) or with 50% of the mean daily intake of the C-females from 6.5 dpc (calorie-restricted females) (R-females), and compared male reproductive findings between 17.5-dpc-old male mice delivered from C-females (C-fetuses) and those delivered from R-females (R-fetuses) and between 6-week-old male mice born to C-females (C-offspring) and those born to R-females (R-offspring).Results: Compared with the C-fetuses, the R-fetuses had (1) morphologically normal external genitalia with significantly reduced anogenital distance index, (2) normal numbers of testicular component cells, and (3) significantly low intratesticular testosterone, in association with significantly reduced expressions of steroidogenic genes. Furthermore, compared with the C-offspring, the R-offspring had (1) significantly increased TUNEL-positive cells and normal numbers of other testicular component cells, (2) normal intratesticular testosterone, in association with normal expressions of steroidogenic genes, (3) significantly reduced sperm count, and normal testis weight and sperm motility, and (4) significantly altered expressions of oxidation stress-related, apoptosis-related, and spermatogenesis-related genes.Conclusions: The results, together with the previous data including the association between testosterone deprivation and oxidative stress-evoked apoptotic activation, imply that reduced fetal testosterone production is the primary underlying factor for the development of TDS in intrauterine hyponutrition, and that TDS is included in the clinical spectrum of Developmental Origins of Health and Disease.


  • Open Access

    Gross appearance of the fetal membrane on the placental surface is associated with histological chorioamnionitis and neonatal respiratory disorders

    by Yoshimasa Horikoshi, Chizuko Yaguchi, Naomi Furuta-Isomura, Toshiya Itoh, Kenta Kawai, Tomoaki Oda, Masako Matsumoto, Yukiko Kohmura-Kobayashi, Naoaki Tamura, Toshiyuki Uchida, et al.

    An opaque fetal membrane based on gross appearance is traditionally indicative of histological chorioamnionitis; however, to the best of our knowledge, there is currently no supportive evidence, and its diagnostic efficiency has not yet been scientifically demonstrated. The present study aimed to provide scientific insights into the traditional concept of an opaque fetal membrane based on gross appearance being an indicator of histological chorioamnionitis. We examined the placental pathology after screening of the placental gross appearance and perinatal complications and did not examine uncomplicated deliveries. We investigated the relationship between the presence of an opaque fetal membrane and histological chorioamnionitis (Cohort 1, 571 placentas) or the outcomes of neonates delivered at term (Cohort 2, 409 placentas) at Hamamatsu University School of Medicine between 2010 and 2017. The judgment of a positive opaque fetal membrane based on gross appearance correlated with histological chorioamnionitis (Cohort 1). Its sensitivity and specificity were 66.7 and 89.9%, respectively, while positive and negative predictive values were 86.8 and 73.0%, respectively. The judgment of a positive opaque fetal membrane based on gross appearance significantly correlated with chorioamnionitis-related complications in term newborns after adjustments for confounding factors (OR;1.82 [1.07–3.11], P<0.05) (Cohort 2). A correlation was observed even after adjustments for confounding factors. The present study is the first to demonstrate that the judgment of a positive opaque fetal membrane based on gross appearance correlated with histological chorioamnionitis as well as chorioamnionitis-related complications in newborns delivered at term. The present results provide support for the traditionally-described importance of gross inspections for an opaque fetal membrane soon after birth.


  • Open Access

    Efficacy and safety of controlled‐release dinoprostone vaginal delivery system (PROPESS) in Japanese pregnant women requiring cervical ripening: Results from a multicenter, randomized, double‐blind, placebo‐controlled phase III study

    by Hiroaki Itoh, Keisuke Ishii, Naoya Shigeta, Atsuo Itakura, Hiromi Hamada, Takeshi Nagamatsu, Tomohiko Ishida, Yasuaki Bungyoku, Ali Falahati, Miori Tomisaka, et al.

    Aim: To evaluate the efficacy and safety of dinoprostone vaginal insert (PROPESS) in pregnant post‐term Japanese women requiring cervical ripening.Methods: This randomized, double‐blind, placebo‐controlled study included 114 pregnant Japanese women at term (41 weeks of gestation) requiring cervical ripening (baseline Bishop score (BS) ≤ 4). The primary end‐point was the proportion of subjects with successful cervical ripening defined as BS ≥ 7 or vaginal delivery in 12 h. The secondary end‐points were changes in BS, proportion of women with vaginal delivery, proportion of women receiving mechanical cervical ripening procedure and use of oxytocic drugs.Results: PROPESS administration for a maximum of 12 h showed significantly higher successful cervical ripening rate (47.4% vs 14.3%, respectively; treatment contrast [TC]: 33.1%; P = 0.0002). The median time from administration to vaginal delivery was significantly shorter in the PROPESS group than in the placebo group (26.18 h vs 33.02 h; OR 2.51; 95% CI [1.60–3.92]; P < 0.0001). In the PROPESS group, the dosage of uterotonic drugs, such as oxytocin, decreased, and the number of patients who used these drugs also decreased.Conclusion: PROPESS administration for a maximum of 12 h was an effective and well‐tolerated treatment for pregnant Japanese women post‐term requiring cervical ripening.


  • Open Access

    The fetal/placental weight ratio is associated with the incidence of atopic dermatitis in female infants during the first 14 months: The Hamamatsu Birth Cohort for Mothers and Children (HBC Study)

    by Masako Matsumoto, Kenji J. Tsuchiya, Chizuko Yaguchi, Yoshimasa Horikoshi, Naomi Furuta-Isomura, Tomoaki Oda, Yukiko Kohmura-Kobayashi, Naoaki Tamura, Toshiyuki Uchida, Hiroaki Itoh

    Background: Among atopic diseases, atopic dermatitis is the most common allergic disease in children and influences both infantile and parental quality of life. Objective: The present study investigated the sex-specific relationship between the fetal/placental weight ratio and The incidence of atopic dermatitis in infants during the first 14 months of life. Methods: Study participants were 922 infants (462 female and 460 male) from singleton pregnancies enrolled in the Hamamatsu Birth Cohort for Mothers and Children (HBC Study) after the exclusion of 298 with missing data on atopic dermatitis. The enrollment of infants with atopic dermatitis was based on a positive response from parents regarding whether a physician had ever diagnosed their child with atopic dermatitis by 14 months of age. The two-sample Wilcoxon rank-sum test or χ2 test was adopted for descriptive analyses where appropriate. Unadjusted odds ratios and 95% confidence intervals for the infantile incidence of atopic dermatitis were compared using logistic regression analyses. Results: Maternal and perinatal factors did not correlate with the incidence of infantile atopic dermatitis. Fetal/placental weight ratio, but not birth or placental weight, correlated with the incidence of atopic dermatitis in female, but not male, infants. A correlation was still observed after adjustments for maternal allergies, gestational age at birth, maternal smoking during pregnancy, and household income at birth (odds ratio: 1.57; 95% confidence interval, 1.05–2.33). Conclusion: We speculated that the intrauterine fetal environment, represented by a relatively small placenta, programs a predisposition in only female infants to atopic dermatitis during the first 14 months of life.


  • Open Access

    Plasticity of histone modifications around Cidea and Cidec genes with secondary bile in the amelioration of developmentally-programmed hepatic steatosis

    by Jeenat Ferdous Urmi, Hiroaki Itoh, Keiko Muramatsu-Kato, Yukiko Kohmura-Kobayashi, Natsuyo Hariya, Divyanu Jain, Naoaki Tamura, Toshiyuki Uchida, Kazunao Suzuki, Yoshihiro Ogawa, et al.

    We recently reported that a treatment with tauroursodeoxycholic acid (TUDCA), a secondary bile acid, improved developmentally-deteriorated hepatic steatosis in an undernourishment (UN, 40% caloric restriction)in uteromouse model after a postnatal high-fat diet (HFD). We performed a microarray analysis and focused on two genes (Cidea and Cidec) because they are enhancers of lipid droplet (LD) sizes in hepatocytes and showed the greatest up-regulation in expression by UN that were completely recovered by TUDCA, concomitant with parallel changes in LD sizes. TUDCA remodeled developmentally-induced histone modifications (dimethylation of H3K4, H3K27, or H3K36), but not DNA methylation, around the Cidea and Cidec genes in UN pups only. Changes in these histone modifications may contribute to the markedly down-regulated expression of Cidea and Cidec genes in UN pups, which was observed in the alleviation of hepatic fat deposition, even under HFD. These results provide an insight into the future of precision medicine for developmentally-programmed hepatic steatosis by targeting histone modifications.


  • Oncoprotective Effects of Short-Chain Fatty Acids on Uterine Cervical Neoplasia

    by Madoka Matsuya-Ogawa, Toshiaki Shibata, Hiroaki Itoh, Hirotake Murakami, Chizuko Yaguchi, Kazuhiro Sugihara, Naohiro Kanayama

    Short-chain fatty acids (SCFAs) produced by fermentation from prebiotics not only provide energy but also activate cell membrane receptors, thereby contributing to the maintenance of homeostasis in the human body. Recently, free fatty acid receptor 2 (FFAR2), which uses SCFAs as ligands, was found to exert oncoprotective effects on several types of neoplasia. This study examined whether SCFAs have oncoprotective effects on uterine cervical neoplasia. Immunohistochemical analysis revealed that FFAR2 was expressed in atypical cells and cancer cells of cervical neoplasia. Moreover, reverse transcription polymerase chain reaction showed that FFAR2 was expressed in a human cervical cancer cell line, HeLa. We also found that SCFAs inhibited the proliferation of HeLa cells, and a FFAR2 antagonist, GLPG0974, used to suppress the binding of SCFAs significantly restored the cell viability of HeLa cells blocked by acetic acid treatment. These results suggest that ingestion of prebiotics and the resulting production of SCFAs may play an oncoprotective role against uterine cervical neoplasia via FFAR2 expression.


  • Congenital Cytomegalovirus Infection

    by Kenta Kawai, Hiroaki Itoh

    A 35-year-old woman presented to the obstetrical clinic for routine fetal ultrasonography at 24 weeks of gestation. Her medical history was notable for a febrile illness that had occurred shortly after conception. Ultrasonographic images showed ventricular dilatation in the fetal brain, and T2-weighted magnetic resonance imaging revealed ventriculomegaly (Panel A) and cerebellar hypoplasia. Maternal serum immunoassay was positive for cytomegalovirus (CMV) IgG and IgM antibodies. At 38 weeks of gestation, the woman had a normal vaginal delivery of a male baby weighing 2556 g (8th percentile) with a head circumference of 30.5 cm (1st percentile). Petechiae were observed on the newborn’s face and trunk. Laboratory evaluation revealed a platelet count of 136,000 per cubic millimeter (reference range, 150,000 to 450,000) and normal hematocrit and aminotransferase levels. Computed tomographic scans of the newborn’s brain showed ventricular dilatation, parenchymal hypoplasia with polymicrogyria, and periventricular calcifications (Panel B, arrows). Immunohistochemical testing of the placenta was positive for CMV, and polymerase-chain-reaction testing of the newborn’s urine revealed CMV DNA — findings that confirmed congenital CMV infection. Congenital CMV infection can be asymptomatic, or symptoms can include growth restriction, hematologic disorders, and sensorineural developmental disorders that range in severity from mild to severe. The newborn was treated with ganciclovir. At a follow-up visit at 11 months of age, the child had sensorineural hearing loss in the right ear, epilepsy, spastic quadriparesis, and developmental delay; treatment included antiepileptic medication and developmental services.


  • Developmental Origins of Nonalcoholic Fatty Liver Disease (NAFLD)

    by Hiroaki Itoh, Naohiro Kanayama

    Nonalcoholic fatty liver disease (NAFLD) is a hepatic manifestation of metabolic syndrome. Its prevalence is currently increasing not only in developed obese countries but also in developing countries. Recent findings from human cohorts and animal studies suggest that a nutritional imbalance in the early critical period is causatively associated with the incidence of NAFLD in later life. Based on the current theory of the developmental origins of health and disease (DOHaD), undernourishment and overnourishment in utero are both hypothesized to prime the predisposition for hepatic fat storage. Current knowledge on the developmental origins of NAFLD is introduced in this chapter.


  • Open Access

    Placental pathology predicts infantile physical development during first 18 months in Japanese population: Hamamatsu birth cohort for mothers and children (HBC Study)

    by Chizuko Yaguchi, Hiroaki Itoh, Kenji J. Tsuchiya, Naomi Furuta-Isomura, Yoshimasa Horikoshi, Masako Matsumoto, Ferdous U. Jeenat, Muramatsu-Kato Keiko, Yukiko Kohmura-Kobatashi, Naoaki Tamura, et al.

    The present study aimed to investigate the relationship between placental pathological findings and physiological development during the neonate and infantile periods. Study participants were 258 infants from singleton pregnancies enrolled in the Hamamatsu Birth Cohort for Mothers and Children (HBC Study) whose placentas were stored in our pathological division. They were followed up from birth to 18 months of age. Physiological development (body weight and the ponderal index [PI]) was assessed at 0, 1, 4, 6, 10, 14, and 18 months. Placental blocks were prepared by random sampling and eleven pathological findings were assessed, as follows: ‘Accelerated villous maturation’, ‘Decidual vasculopathy’, ‘Thrombosis or Intramural fibrin deposition’, ‘Avascular villi’, ‘Delayed villous maturation’, ‘Maternal inflammatory response’, ‘Fetal inflammatory response’, ‘Villitis of unknown etiology (VUE)’, ‘Deciduitis’, ‘Maternal vascular malperfusion’, and ‘Fetal vascular malperfusion’. Mixed model analysis with the use of the xtmixed command by the generic statistical software, Stata version 13.1., identified ‘Accelerated villous maturation’ and ‘Maternal vascular malperfusion’ as significant predictors of a lower body weight and ‘Deciduitis’ as a significant predictor of a small PI, throughout the first 18 months of life. In conclusion, the present study is the first to demonstrate that some pathological findings of the placenta are associated with changes in infantile physical development during the initial 18 months of life in the Japanese population.